Post-progression survival after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor for advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.

被引：0
|
作者：
Kogure, Yoshihito
Kitagawa, Chiyoe
Oki, Masahide
Saka, Hideo
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
[2] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19005
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced non-small cell lung cancer with uncommon mutations: A multicenter observational study
    Kanazu, M.
    Mori, M.
    Shiroyama, T.
    Nagatomo, I.
    Ihara, S.
    Komuta, K.
    Suzuki, H.
    Hirashima, T.
    Kimura, M.
    Imamura, F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [42] Epidermal growth factor receptor tyrosine kinase inhibitor in treatment of brain metastasis from non-small cell lung cancer
    Zhang, Lan-jun
    Cai, Ling
    Zhu, Jian-fei
    Rong, Tie-hua
    Wu, Shao-xiong
    Chen, Zhong-pin
    Liu, Meng-zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [44] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Yan Zhang
    Zheng Wang
    Xuezhi Hao
    Xingsheng Hu
    Hongyu Wang
    Yan Wang
    Jianming Ying
    Chinese Journal of Cancer Research, 2017, 29 (01) : 18 - 24
  • [45] Clinical characteristics and response to tyrosine kinase inhibitors of patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations
    Zhang, Yan
    Wang, Zheng
    Hao, Xuezhi
    Hu, Xingsheng
    Wang, Hongyu
    Wang, Yan
    Ying, Jianming
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (01) : 18 - 24
  • [46] Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Nishinarita, Noriko
    Igawa, Satoshi
    Kasajima, Masashi
    Kusuhara, Seiichiro
    Harada, Shinya
    Okuma, Yuriko
    Sugita, Keisuke
    Ozawa, Takahiro
    Fukui, Tomoya
    Mitsufuji, Hisashi
    Yokoba, Masanori
    Katagiri, Masato
    Kubota, Masaru
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    ONCOLOGY, 2018, 95 (02) : 109 - 115
  • [47] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Jumpei Kashima
    Yusuke Okuma
    Maki Miwa
    Yukio Hosomi
    Medical Oncology, 2016, 33
  • [48] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
    Ning, Ye
    Bao, Minwei
    Yan, Xiaoxia
    Xie, Dong
    Jiang, Gening
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
  • [49] ACTIVATION OF CYTOMEGALOVIRUS IN A PATIENT ON EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR TREATMENT IN NON-SMALL CELL LUNG CANCER
    Dawes, Sean M.
    Plichta, Christine
    Gaddipati, Himaja
    Hamade, Sam
    Biedny, Adam
    de Villate, Oscar F. Parodi Ortiz
    CHEST, 2023, 164 (04) : 972A - 973A
  • [50] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Kashima, Jumpei
    Okuma, Yusuke
    Miwa, Maki
    Hosomi, Yukio
    MEDICAL ONCOLOGY, 2016, 33 (11)
12345